Inhibition Effects and Mechanism Study of rAj-HRP30, a Recombinant Histidine-Rich Peptide from Apostichopus japonicus, on the Viability of Pancreatic Ductal Adenocarcinoma Cells Panc01 and Panc02
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041485 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yuyao Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Agriculture and Rural Affairs Key Lab of Protection and Utilization of Aquatic Germplasm Resource, Liaoning Province Key Lab of Germplasm…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Stichopus, Peptides. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Revitalization Talents Program, Science & Technology Project of Liaoning Province.
Abstract (Originalsprache)
rAj-HRP30 is a recombinant peptide derived from the wild-type rAj-HRP of Apostichopus japonicus through a gene-shortening mutation. It has a high histidine content (53.3% in its primary structure) and a molecular weight of 3.919 kDa, classifying it as a histidine-rich peptide. The literature reports indicate that human histidine-rich peptides exhibit antitumor activity. Previous research by our group demonstrated similar properties in rAj-HRP, the precursor of rAj-HRP30. Therefore, this study used Panc01 (human) and Panc02 (mouse) cells—highly malignant models with limited targeted therapies—to investigate the antitumor activity and mechanisms of rAj-HRP30 and evaluate its potential for pancreatic cancer treatment. This study designed a gene-shortening strategy for rAj-HRP and artificially synthesized the gene sequence of rAj-HRP30. The cDNA sequence of rAj-HRP30 was cloned into the pET23b vector, and the recombinant plasmid pET23b-HRP30 was transformed into E. coli BL21 for expression. Following IPTG induction, the recombinant peptide was purified using nickel ion affinity chromatography, yielding rAj-HRP30 with a purity exceeding 95%. rAj-HRP30 markedly inhibited the adhesion, migration, and invasion of Panc01 and Panc02 cells. It also disrupted cellular morphology and cytoskeletal structure while inducing apoptosis. These effects were dose-dependent. After confirming the in vitro anticancer activity of rAj-HRP30, this study employed Panc02 cells as a model to investigate its inhibitory mechanisms using Western blot analysis. The results revealed that rAj-HRP30 reduced FGFR1 expression in Panc02 cells and inhibited the downstream FYN and FAK signaling pathways, subsequently blocking the PI3K/AKT signaling and apoptosis pathways. In the apoptotic pathway, rAj-HRP30 was able to downregulate the expression of Bcl-2, Caspase-9, Caspase-3, Caspase-7, and PARP1 and upregulate the expression of Bax, cleaved Caspase-9, cleaved Caspase-3, cleaved Caspase-7, and cleaved-PARP1 to induce apoptosis in Panc02 cells. Furthermore, rAj-HRP30 also downregulated the expression of MMP2 and MMP9, thereby inhibiting the migration and invasion of Panc02 cells. Conclusion: rAj-HRP30 exhibits significant inhibitory effects on pancreatic ductal adenocarcinoma Panc01 and Panc02 cells in vitro. Its mechanism involves FGFR1-related signaling and apoptosis pathways. rAj-HRP30 shows promise as a therapeutic agent targeting FGFR for pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ministry of Agriculture and Rural Affairs Key Lab of Protection and Utilization of Aquatic Germplasm Resource, Liaoning Province Key Lab of Germplasm Improvement and Fine Seed Breeding of Marine Aquatic Animals, Liaonin…
- School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
- Department of Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.
Förderung
- National Natural Science Foundation of China
- Liaoning Revitalization Talents Program
- Science & Technology Project of Liaoning Province
- Liaoning Provincial Excellent Young Scholars Fund
- China Postdoctoral Science Foundation
- Dalian Science and Technology Talent Innovation Support Program
- Science and Technology Project of Liaoning Province
Zitieren
APA
Song, Y., Gao, S., Jiang, J., Zhang, Y., Zhang, J., Wang, X., Lv, L., Zhou, Z., & Wang, J. (2025). Inhibition Effects and Mechanism Study of rAj-HRP30, a Recombinant Histidine-Rich Peptide from Apostichopus japonicus, on the Viability of Pancreatic Ductal Adenocarcinoma Cells Panc01 and Panc02. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041485
Vancouver
Song Y, Gao S, Jiang J, Zhang Y, Zhang J, Wang X, et al. Inhibition Effects and Mechanism Study of rAj-HRP30, a Recombinant Histidine-Rich Peptide from Apostichopus japonicus, on the Viability of Pancreatic Ductal Adenocarcinoma Cells Panc01 and Panc02. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041485
BibTeX
@article{Song2025,
author = {Song, Yuyao and Gao, Shan and Jiang, Jingwei and Zhang, Yuebin and Zhang, Jingyu and Wang, Xiaona and Lv, Li and Zhou, Zunchun and Wang, Jihong},
title = {Inhibition Effects and Mechanism Study of rAj-HRP30, a Recombinant Histidine-Rich Peptide from Apostichopus japonicus, on the Viability of Pancreatic Ductal Adenocarcinoma Cells Panc01 and Panc02},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041485}
}
EUVIMED